Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug consisting of mometasone (typically used as its ester, mometasone furoate), a synthetic corticosteroid with potent anti-inflammatory activity, and phenethicillin (also known as pheneticillin), an oral penicillin-class antibiotic. Mometasone acts by binding to glucocorticoid receptors to modulate gene expression and suppress inflammatory pathways. Phenethicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bactericidal effects against susceptible organisms. This combination would theoretically provide both anti-inflammatory and antibacterial effects for conditions where both inflammation and infection are present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mometasone + phenethicillin.